Related Experiment Video

Updated: May 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Simvastatin induces apoptosis in castrate resistant prostate cancer cells by deregulating nuclear factor-κB pathway

Yong Hyun Park1, Su Yeon Seo, Eunhye Lee

  • 1Seoul National University Hospital, Seoul, Korea.

The Journal of Urology
|October 23, 2012
PubMed
Abstract

Insights

Simvastatin reduces castrate-resistant prostate cancer cell growth by inducing apoptosis. This occurs through inhibiting the nuclear factor-kappa B pathway, impacting cell survival signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Castrate-resistant prostate cancer (CRPC) remains a significant clinical challenge.
  • Identifying novel therapeutic strategies targeting CRPC cell survival is crucial.

Purpose of the Study:

  • To investigate the cytotoxic effects of simvastatin on CRPC cells.
  • To elucidate the underlying molecular mechanisms, particularly the involvement of the nuclear factor-kappa B (NF-κB) pathway.

Main Methods:

  • Cell viability and apoptosis assays (colorimetric, Annexin-V/PI staining) were performed on PC3 and DU-145 cells treated with simvastatin.
  • Western blot analysis assessed IκBα and p65 protein expression and localization.
  • NF-κB transcriptional activity was measured using a luciferase reporter assay.

Main Results:

  • Simvastatin decreased cell viability and increased apoptosis in a dose- and time-dependent manner.
  • Simvastatin inhibited IκBα phosphorylation and nuclear translocation of p65.
  • Simvastatin suppressed NF-κB transcriptional activity and downregulated NF-κB-regulated genes (cIAP-1, cIAP-2, cFLIP-S, XIAP).

Conclusions:

  • Simvastatin exhibits anti-cancer effects in CRPC cells by inducing apoptosis.
  • The mechanism involves the inhibition of the NF-κB signaling pathway, including IκBα phosphorylation and p65 nuclear translocation.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.